DocGo Operating Cycle from 2010 to 2026

DCGO Stock  USD 0.76  0.03  3.48%   
DocGo Operating Cycle yearly trend continues to be very stable with very little volatility. Operating Cycle is likely to drop to 84.28. During the period from 2010 to 2026, DocGo Operating Cycle quarterly data regression pattern had sample variance of  470.32 and median of  76.80. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
112.37
Current Value
84.28
Quarterly Volatility
21.6867749
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check DocGo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DocGo's main balance sheet or income statement drivers, such as Tax Provision of 17.4 M, Depreciation And Amortization of 11 M or Interest Expense of 2.4 M, as well as many indicators such as Price To Sales Ratio of 0.77, Dividend Yield of 2.4 K or PTB Ratio of 1.48. DocGo financial statements analysis is a perfect complement when working with DocGo Valuation or Volatility modules.
  
Build AI portfolio with DocGo Stock
Check out the analysis of DocGo Correlation against competitors.
Evaluating DocGo's Operating Cycle across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into DocGo Inc's fundamental strength.

Latest DocGo's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of DocGo Inc over the last few years. It is DocGo's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DocGo's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

DocGo Operating Cycle Regression Statistics

Arithmetic Mean89.41
Geometric Mean87.43
Coefficient Of Variation24.26
Mean Deviation15.44
Median76.80
Standard Deviation21.69
Sample Variance470.32
Range76.4319
R-Value0.64
Mean Square Error298.71
R-Squared0.40
Significance0.01
Slope2.73
Total Sum of Squares7,525

DocGo Operating Cycle History

2026 84.28
2025 112.37
2024 124.85
2023 153.23
2022 91.06
2021 89.77
2020 96.42

About DocGo Financial Statements

DocGo investors utilize fundamental indicators, such as Operating Cycle, to predict how DocGo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 112.37  84.28 

Pair Trading with DocGo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DocGo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DocGo will appreciate offsetting losses from the drop in the long position's value.

Moving together with DocGo Stock

  0.72IL3 Integra LifeSciences Earnings Call This WeekPairCorr
  0.75EW Edwards Lifesciences CorpPairCorr

Moving against DocGo Stock

  0.85EDAP EDAP TMS SAPairCorr
  0.77HYB HOYAPairCorr
  0.77EKSO Ekso Bionics HoldingsPairCorr
  0.76VREX Varex Imaging CorpPairCorr
  0.63DXCM DexCom IncPairCorr
The ability to find closely correlated positions to DocGo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DocGo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DocGo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DocGo Inc to buy it.
The correlation of DocGo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DocGo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DocGo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DocGo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DocGo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DocGo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Docgo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Docgo Inc Stock:
Check out the analysis of DocGo Correlation against competitors.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Will Health Care Equipment & Supplies sector continue expanding? Could DocGo diversify its offerings? Factors like these will boost the valuation of DocGo. Projected growth potential of DocGo fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DocGo data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.09
Earnings Share
(0.53)
Revenue Per Share
3.68
Quarterly Revenue Growth
(0.49)
Return On Assets
(0.09)
Investors evaluate DocGo Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating DocGo's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause DocGo's market price to deviate significantly from intrinsic value.
It's important to distinguish between DocGo's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DocGo should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, DocGo's market price signifies the transaction level at which participants voluntarily complete trades.